SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-055854
Filing Date
2020-05-04
Accepted
2020-05-04 07:12:31
Documents
16
Period of Report
2020-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018457d1_8k.htm   iXBRL 8-K 58634
2 EXHIBIT 2.1 tm2018457d1_ex2-1.htm EX-2.1 709333
3 EXHIBIT 3.1 tm2018457d1_ex3-1.htm EX-3.1 4415
4 EXHIBIT 99.1 tm2018457d1_ex99-1.htm EX-99.1 100467
5 EXHIBIT 99.2 tm2018457d1_ex99-2.htm EX-99.2 25503
  Complete submission text file 0001104659-20-055854.txt   1277616

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA stml-20200504.xsd EX-101.SCH 3186
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE stml-20200504_lab.xml EX-101.LAB 34591
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stml-20200504_pre.xml EX-101.PRE 22710
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2018457d1_8k_htm.xml XML 3734
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35619 | Film No.: 20842737
SIC: 2834 Pharmaceutical Preparations